Where To Invest Now and Options Trading Newsletter

Stock Market Investing Strategies

Read the December 7, 2015 Where To invest Now Options Trading Newsletter in .pdf format – Click Here

December 7, 2015

Market Strategies Newsletter

Sample Issue

 Stock Market Investing Strategies

Balanced Investing Strategies To

Make Money In Up Or Down Markets


A Publication of Princeton Research, Inc. (www.PrincetonResearch.com)

Contributing Staff: Michael King, Charles Moskowitz

 Stock Market Investing Strategies

Where To Invest In 2015 Newsletter Covering:


Where to Invest December 2015

Best Stocks To Buy December 2015

Stock Market Investing Strategies

Stock Options Trade Alerts

Options Trading Strategies

How To Trade Options


2015 YTD Profits $ 8216


Over 82% Returns



2014 Profits = $ 20,443

Over 204% Returns


NOTE: This is a Sample Issue Only!



Visit: PrincetonResearch.com/join.htm



For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm


Where To Invest Now

$10,000 Trading Portfolio
Charles Moskowitz Discussion


We Have 2 open long positions:


CCOI  Jan 35 Calls

FB Dec 110 Calls


Funds in Use = $1,080



Week 49 was produced a small loss, but that really wasn’t the whole story.

The losses in HOG and GILD were the “second half” of trades that we closed out last week either by text or 100% Up rules.  For the week we lost $ . 92 bringing YTD gains to $8,216.  Funds in use are $1080.


The action this week also brought up many questions about the validity of our 50% Down rule.  I can only say that this rule has saved us money about 95% of the time, but after being stopped out of our position in the TBT calls on Wednesday before a 350% move on Thursday I am willing to make an exception to this rule.  This will only occur when we are getting a move based on overnight or premarket action AND there is a text message with a new stop issued prior to the open.  In the case of the TBT (reverse 20-year bond ETF) I have continuously discussed in this space that bond yields will not only rise, but the change in TREND of interest rates happens rarely and the new trend generally stays in place for multiple years.


As Mike King discusses later in this weeks letter, the Gold market has made some real headway this week.  Is it a bottom, or just a short-covering rally off a dramatically oversold commodity??  Mike has pointed out that there is a seasonal tendency for a long Gold position to work in this current timeframe.  In studying the chart on gold, I see something that generally doesn’t occur often; a “key reversal.”  This occurs when any market undergoes a steady and extreme rise or decline, followed by new contract low (or high) followed by a reversal in price and closing at the extreme end of the range.  Gold has had a 4 year decline from 1900 to this weeks low of 1057, a move of almost 45%.  Clearly that was a major decline.


I want to also point out that a very smart friend of mine pointed out to me 2 weeks ago that many of the futures markets were getting into areas that he felt warranted participation on the “long” side.  What he said was, “You know that these markets can’t go to zero, They aren’t stocks that can go out of business and go to zero, these are “stuff” and we continue to value them.”  Well, this week all that “stuff” moved higher.  Wheat made a new low and then rallied, as did soybeans, cattle, hogs, cocoa, sugar, and cotton.  The point is….these are the building blocks of inflation.  While the metals aren’t known for rallying with interest rates moving higher, those rates are probably not going very far very fast……CAM




Market Strategies $10,000 Trading Account Trade Table


New Trades Options account:


    ( 1 ) Buy 4 January GLD 104 Calls @ $ 1.50

    ( 2 ) Buy 4 CRM January 82.50 Calls @ $ 2.25


12/04 Bought 6 FB December 110 Calls 0.57   342
12/03 Sold 2 SPY December 207.50 Puts 4.17     834       302 Gain
12/03 Sold 3 SPY December 207.50 Puts 3.72   1116       318 Gain
12/03 Bought  5 SPY December 207.50 Puts 2.66 1330
12/02 Sold 6 TBT December 45 Calls 0.33     198       192 Loss
12/02 Sold 4 GILD December 110 Calls 0.54     216       180 Loss
12/02 Sold 4 HOG December 50 Calls

( 50% Loss Rule )

0.40     160       160 Loss
12/01 Sold 4 MAR December 75 Calls

( 50% Loss Rule )

0.45     180       180 Loss
11/30 Bought 6 TBT December 45 Calls 0.65   390
11/27 Sold 4 GILD December 110 Calls 1.58     632       236 Gain
11/24 Bought 8 GILD  December 110 Calls 0.99   792
11/23 Bought 6 CCOI January 35 Calls 0.85   510
11/23 Bought 4 MAR December 75 Calls 0.90   360
11/20 Sold 4 HOG Dec 50 Calls

( 100% Profit Rule )

1.60      640       320 Gain
11/17 Bought 8 HOG December 50 Calls 0.80   640


Remember, these trades are based on your participation in the

Subscriber Members Only



Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.


For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm

Where to Invest December 2015

MARKET Laboratory – Weekly Changes


Prices are copied from Barron’s Weekly and Yahoo Finance and may be incorrect.









S&P 500








Russell 2000








Gold (spot)












Heating Oil




Unleaded Gas




Natural Gas








Put/Call Ratios

S&P 100



Put/Call Ratios

CBOE Equity





153-25 -02

3.02% +0.02%

10 Yr. Note

125-294-186         2.27%+0.05%






CRB Inflation




No change

Barron’s* Confidence







5 Yr. Note

118-134 -098

1.71% +0.06%






DJ Utilities








Long Term

















M1 Money  Supply


Nov 23rd


M-2 Money



Nov 23rd




M1…all money in hands of the public, Time Deposits Traveler’s Checks, Demand Deposits
M2.. adds Savings and Money Market Accounts both compared with the previous year.


Market Strategies Technical Information


                              Support/Resistance Levels:                SUPPORT                         RESISTANCE


S&P 500             2051                                   2125

Dow                 17,633                                 18,088

QQQ            112.00                                 116.90

Transports        81.03                                    8457

NASDAQ           5050                                             5278


$100,000 Trading Portfolio Stock Positions and Trades


Each stock is allocated a theoretical $ 5,000 share of the portfolio unless otherwise indicated.





Purchase Price Purchase Date Stop/Loss   Price/Date Sold   Profit/


GLW     100 18.78       11/24
LVLT    100 50.81       11/23
SPXU   100 30.08       11/02 31.83  12/03 $ 175
TWTR  200 28.51       10/28
SPXU  200 34.10       10/15
CUBA   500   7.58       09/28
MOS  100 43.55       08/14
CRM  100 72.90       04/29      66.25
NBG  600 1.40       02/17
BAC. Wts 5,000 lots 0.7411       12/26
BSBR  500






SAN  600 8.40      12/16
AA  500 14.21      10/16
FCX 150 34.99      09/09    7.75
NBG 300   2.95      05/19
NBG 300 4.08 8/12
TEXQY* 200 6.56 7/11
REPR* 5000 0.22 10/22/12


Remember, these trades are based on your participation in the

Subscriber Members Only




Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.

For those of you who do not buy puts to protect your portfolio, there are many ETF’s that are the inverse of the DOW. The symbols are DOG, DXD, SDS,TZA and RWM, which go up when the  DOW, S&P 500 and Russell 2000 go down and down when they go up. The DZZ goes up double when gold goes down.


Where to invest Stocks to buy

Market Strategies $100,000 Trading Account


             New Options Trades :

                        ( 1 )  Buy 8 GLD January 104 Calls @ $ 1.50

                        ( 2 )  Buy 8 CRM January 82.50 Calls @ $ 2.25


There were six closed option positions:


16 GILD December 110 Calls bought at $ 0.99 with half or 8 lots sold at $ 1.58 made a $ 472 profit credited the previous week.  However for last week the balance of 8 were sold at a loss of $ 360.


The 8 lots of the remaining HOG Calls had the same fate, a loss of $ 320.


The Marriott ( MAR ) 75 Calls were also stopped out on the 50% loss rule losing $ 360.


The TBT’s bought Dec 2nd were the right idea, but poor timing lost $ 384 as they were also stopped out on the 50% Loss Rule.


The total amount of the losses added up to $ 1,424.


On the plus side, 10 SPY Puts were bought on Dec3rd and sold on the same day making $ 1,285.


The options losses totaled $ 139.


There was one closed out stock position: 100 shares of the SPXU were sold at $ 31.83 making

a $ 175 profit and saving what might have been a losing week to make $ 36 after losing $ 139 in the options trades.


For the year to date we have gains of $ 22,271. 


In addition there is a credit of $ 245 for the sold CRM Call.


Open position losses in the stock account decreased by $ 955 to $ 15,767.


The options expire on the third Friday of each Month unless otherwise posted.


The Stock table has the following 18 positions:





The options call for a $ 2,500 investment unless otherwise stated; each stock position requires $5,000 unless otherwise mentioned specifically.


We are basing money management on a hypothetical

$ 100,000 and are using a total of $61,721 for the 17 open stock positions.

There is one long option position requiring $ 640, which added to the stock longs total an

outlay of $ 62,361 leaving $ 37,639 in cash.


The long option position in the table below are the profitable HOG Calls..


There is also the open sale of one CRM December $ 82.50 Call against the 100 shares long.


These figures are approximate and there might be errors.


We have not counted the dividends received from Apple, JP Morgan, North American Tankers, Santander, their Brazil affiliate BSBR and Blue Capital Reinsurance which was sold for a profit and many others.


Executions that have occurred at or near the open or close of trading sometimes vary from our actual numbers.  For example, when something opens down and it is through our price, we take the next trade whether it is an uptick or continues lower.  This sometimes results in a 50% trade that is slightly above or below the exact number.



Previous Week’s Recommendations and

Rules for the Market Strategies

$100,000 Portfolio Trading Account


  • All options count for about $ 2,500.00 for model portfolio calculations unless

otherwise stated


  • When the option has doubled sell half the position


  • Stop Loss protection is either half or offered with each trade


  • The cost of the option is the asking price (or the price between the bid and ask,

whichever is more realistic)


  • The options will be followed until closed out.


  • Option Symbols are stock symbol with expiration month and strike price



Option Cost Date Sold Date Profit/


FB Dec 110

12 lots



SPY Dec 207.50

10 lots



12/03/15 4.17 sold half

3.72 sold balance




$ 755


$ 530

TBT Dec 45

12 lots




11/30/15 0.33

( 50% Loss Rule )

12/02/1015 ( $ 384 )
GILD Dec 110

16 lots; 8 remain



11/24/15 1.58 Sold Half

0.54 Sold Balance




$ 472


( $ 380 )

CCOI Jan 35

12 lots



MAR Dec 75

8 lots



11/23/15 0.45 ( 50% Loss Rule ) 12/01/2015 ( $ 360 )
CRM Dec 82.50

1 Lot



11/20/15 Wrote against Long $ 245 Credit
HOG Dec 50

16 lots

8 lots remain



11/17/15 1.60

( 100% Profit Rule )

Sold half

0.40 Sold Balance





$ 640



( $ 320 )


Remember, these trades are based on your participation in the

Subscriber Members Only




Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.



For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm



This Weeks’ Economic Numbers

Earnings Releases and Media Data


Before the Open on top of the Row;

After the close below the Economics Information


MONDAY Mattress Firm MFRM ( 0.81 vs 0.70 ) Vail Resorts MTN ( -1.71 vs -1.77 )

15:00 hrs Consumer Credit  October (  18.6 Bln vs 28.9 Bln )

The Federal Reserve Board of Governors meets on proposed amendments to the Dodd-Frank law.

Casey’s General CASY ( 1.51 vs 1.28 ) Central Garden CENT ( -0.09 vs -0.12 ) GW Pharma GWPH ( -0.07 vs 0.01 ) H & R Block HRB ( -0.48 vs -0.45 ) Ocean Rig UDW  GWPH ( -0.07 vs 0.01 ) H & R Block HRB ( -0.48 vs -0.45 ) United Natural Foods UNFI ( 0.68 vs 0.66 ) PEP Boys PBY ( 0.06 vs -0.03 )

TUESDAY Auto Zone  AZO ( 8.24 vs 7.27 ) Conn’s CONN ( 0.27 vs -0.08 ) The Children’s Place  PLCE ( 1.92 vs 1.82 ) Toll Brothers TOLL ( 0.84 vs 0.71 )


10:00 hrs JOLTS – Job Openings  Oct ( NA vs 5.53Mln )


Costco COST ( 1.17 vs 1.12 ) Smith & Wesson SWHC ( 0.20 vs 0.09 ) Krispy Kreme

KKD ( 0.20 vs 0.18 ) Oxford Industries OXM ( -0.09 vs +0.01 ) Qihoo Tech  360 QIHU ( 0.99 vs 0.63 ) Triangle Petroleum TPLM ( -0.12 vs 0.15 ) Sigma SIGM ( 0.09 vs 0.04 )


WEDNESDAY Francesca’s FRAN ( 0.16 vs 0.17 ) Lululemon athletica LULU ( 0.37 vs 0.42 )

Korn/Ferry KFY ( 0.52 vs 0.51 )  Ferrelgas Partners FGP ( -0.17 vs -0.40 )

07:00 hrs  MBA Mortgage Index  12/05   ( NA vs -3.2% )

10:00 hrs  Wholesale Inventories  Oct  (  0.1% vs 0.5%  )

10:30 hrs  Crude Inventories 12/05 ( NA vs +1.177 Mln Bbls )


Men’s Wearhouse MW ( 0.50 vs 0.83 )  Peak Resorts SKIS ( 0.51 vs -1.69 )


THURSDAY Cantel Medical CMN ( 0.36 vs 0.34 ) Ciena CIEN ( 0.38 vs -0.08 ) Greif GEF

( 0.49 vs 0.85 ) Methode Electronics MEI ( 0.53 vs 0.66 )

08:30 hrs Initial Claims 12/05 ( 269K vs 269K )

08:30 hrs Continuing Claims 12/05 ( 2167K vs 2161K )

08:30 hrs Export Prices ex-ag Nov ( NA vs -0.3% )

08:30 hrs Import Prices ex-oil Nov ( NA vs -0.3% )

10:30 hrs Natural Gas Inventories 12/05 ( NA vs -53bcf )

14:00 hrs Treasury Budget Nov ( NA vs -$56.8Bln )

Adobe Systems ADBE ( 0.60 vs 0.36 ) Restoration Hardware RH ( 0.63 vs 0.49 )

Civitas Solutions  CIVI ( 0.36 vs 0.34 ) Finisar FNSR ( 0.23  vs  0.23 )

FRIDAY Big Lots BIG ( 0.00 vs -0.06 ) Genesco GCO ( 1.30 vs 1.28 ) Hovnanian HOV ( 0.10 vs 0.22 ) Medley Capital MCC ( 0.30 vs 0.37 )

Opec Ministers meet and are seen unlikely to change policies

08:30 hrs PPI  Nov ( -0.1% vs -0.4% )

CORE PPI Nov ( 0.1% vs -0.4% )

08:30 hrs Retail Sales Nov ( 0.3% vs 0.1% )

Retail Sales ex-auto ( 0.3% vs 0.2% )

10:00 hrs Business Inventories Oct ( +0.1% vs +0.3% )

10:00  hrs Michigan Sentiment Dec ( 91.6 vs 93.1 )

 Best Stocks To Buy


Market Strategies Fundamentals


Treasuries were steady to higher Friday getting back some of Thursday’s losses despite a huge equity rally in which the Dow rocketed 370 points higher or 2.12% to 17, 847.63. For the entire week the Dow gained just 0.28% but at least all the losses were from Yellen and the Fed’s uncertainties were recovered.  The S&P 500 which found support at its 50 –day price moving average yesterday, soared over 2% Friday to close at 2,091.69 up 1.58 or 0.08% after having been down as low as 2042 and its close last Thursday at 2047.25. a key reversal day on positive fundamentals. The Nasdaq likewise made a powerful reversal closing higher on the day on another key reversal.


However, it was far from all positive as both the Russell and Transportation averages remained lower on the week. The Russell 2000 continued in negative territory down 19 points for the week or 1.6% to 1183.40. Even though it rallied 13 points off the low it still made a lower low and high causing it to have a down day. The Tranny was even much worse. The DJT closed down 3.17% or 260.59 to 7954.83 well below support at 8100. The action of the two indexes certainly leaves a mixed picture going forward.

Rate Of Change: A Very Rare Occurrence  In 2015, the S&P 500’s weekly chart printed something that has only occurred six other times since 1983. The analysis below is an extension of the “rare readings and key reversal” data that occurred on October 2 and October 9. The two rare October events, one November event and one this past Friday are bullish momentum events.

The Rate of Change indicator does exactly what you would expect it to do; it measures the rate of change from one period to the next. chart below shows the rare and extreme set-up that recently occurred in 2015.   

GLD Volumes were above normal last week. Options volume and open interest is going higher.; Buy weakness or any two days down.

Balanced Investing Strategies

Market Strategies Economic Data

The U.S economy added a great deal of jobs over the past three months. The increase of 211K for November comes on the heels of an October revision of 17,000 more jobs and September 8,000 additional which in reality totals 236,000 additional jobs over the past three months more than previously known. Private sector payrolls accelerated:  increasing by 197,000 (Briefing.com consensus 185,000). October private sector payrolls revised to 304,000 from 268,000. September private sector payrolls revised to 165,000 from 149,000. The total of the three months adds up to 52,000 creating 249,000 private sector good -paying jobs.

Unemployment rate continued at a low 5.0% (Briefing.com consensus 5.0%) versus 5.0% in October.

The U6 unemployment rate, which accounts for the total unemployed plus persons marginally attached to the labor force and the underemployed, was 9.9% versus 9.8% in October.

Persons unemployed for 27 weeks or more accounted for 25.7% of the unemployed versus 26.8% in October. Average hourly earnings increased 0.2% (Briefing.com consensus 0.2%) after increasing 0.4% in October. Average hourly earnings rose 2.3% in November versus 2.5% the previous month. The average workweek was lower just 34.5 hours (Briefing.com consensus 34.5) versus 34.6 hours in October.  The manufacturing workweek was unchanged at 40.7 hours.  Factory overtime was unchanged at 3.2 hours. The labor force participation rate was 62.5% versus 62.4% in October. There remains an abundance of usurious welfare.

Productivity Gains  while employment has risen with higher wages has  kept down inflation:

Third quarter productivity was revised up to 2.2% (Briefing.com consensus 2.2%) from 1.6% in the preliminary estimate while unit labor costs were revised up to 1.8% (Briefing.com consensus 1.2%) from 1.4% in the preliminary estimate.

The change in productivity flowed from a 1.8% increase in output and a 0.3% decrease in hours worked. That was the first decline in hours worked since the third quarter of 2009. The change in unit labor costs reflected a 4.0% increase in hourly compensation and a 2.2% increase in productivity. Productivity is up just 0.6% from the same quarter a year ago while unit labor costs are up 3.0%.
Productivity gains help keep down inflation pressures from rising wages in check.  Over the long term, it is productivity gains that provide the increase in output that has led to consistent gains in living standards in free market economies.

Category Q3 Q2 Q1 Q4 Q3
Nonfarm Business Sector
Productivity Q/Q 2.2% 3.5% -1.1% -2.2% 3.1%
Unit Labor Costs Q/Q 1.8% -1.8% 2.6% 5.7% 0.1%
Productivity Y/Y 0.6% 0.8% 0.6% 0.0% 1.4%
Unit Labor Costs Y/Y 3.0% 2.6% 1.2% 2.8% 1.1%


The US trade deficit widened to $43.9 bln from an upwardly revised $42.5 bln (from -$40.8 bln) in September. The Briefing.com consensus estimate expected the trade deficit to be $43.0 bln

October exports were $184.1 bln, which was $2.7 bln less than September exports. October imports were $228.0 bln, which was $1.3 bln less than September imports. The export of goods decreased by $3.1 bln with industrial supplies and materials decreasing $1.6 bln, half of which was the result of a decrease in exports of fuel oil and other petroleum products. Capital goods exports decreased $0.9 bln, paced by a $0.5 bln drop in exports of industrial engines. Consumer goods exports dropped by $0.5 bln., The entirety of that decline came from exports of artwork, antiques, stamps, and jewelry.


The total drop in imports was driven by a $2.0 bln decrease in industrial supplies and materials, which flowed from a $1.1 bln decrease in imports of crude oil and a $0.4 bln decrease in imports of other petroleum products. Capital goods imports increased $0.5 bln while consumer goods imports increased $0.2 bln, with cell phone and other household goods imports (+$0.7 bln) making a key difference there

The real goods deficit increased $3.0 bln to $60.3 bln, which is 2.6% above the third quarter average. That should factor as a negative input for fourth quarter GDP forecasts.

The Chicago PMI report for November was extremely disappointing as the index dropped to 48.7 from 56.2 in October.  The Briefing.com consensus estimate was pegged at 55.0. The downturn in November was led by sharp drops in the index for both new orders (to 44.1 from 59.4) and production (to 50.9 from 63.4). Order backlogs stayed in contraction for the tenth consecutive month.


The overall index has been below 50.0 in two of the last three months.  The new orders index, meanwhile, fell below 50.0 for the sixth time this year.  The dividing line between expansion and contraction is 50.0.

Chicago PMI 48.7 56.2 48.7 54.4 54.7
New Orders 44.1 59.4 49.5 56.7 58.5
Production 50.9 63.4 43.6 59.0 61.8
Employment 51.6 50.6 52.3 49.1 46.2
Prices Paid 42.2 44.3 41.5 47.3 54.5


The U.S. Dollar Index is up 0.37% to 97.98 after making an earlier high of 98.47

The S&P 500 is up 0.92% to 2,068.2

WTI crude: -1.95% to $40.28/bbl.

Gold is up 1.55% to $1,077.60/troy oz.


Market Strategies Cycles


Three sector seasonal trades come to an end in December: Gold & Silver, Semiconductor, and Telecom. The SPDR Gold (GLD) position was originally recommended in the market letter of November 16th.to be bought the following week ( upon a review and opinion by Charles  ) which was the week of the Thanksgiving holiday and it was quite volatile with gold having made a new low on December 2nd before a sharp rebound the GLD having gone from a low of 100.53 to its close last week at 104.32. The GLD volume was huge perhaps triple normal numbers.

The December 18th 193 Calls would have been stopped out if bought on the usual 50% loss rule.  It appears to have made a seasonal bottom and did well considering the commitment by Chair Yellen for higher rates as well as better stock prices. This appears to be a bottoming pattern.


In addition to the GLD the SOXX, iShares DJ Transports (IYT) and Vanguard REIT (VNQ) were added to the Trader’s Almanac portfolio on November 13 leaving only SPDR Technology (XLK) as the last open trade idea. IYT and XLK can be considered on dips below their respective buy limits.


Another seasonal opportunity is the buying of the TBT below 44. selling the TLT above 122. Stops at 42.35 on the TBT and 24 for the TLT and always use the 50% rule on options.


Based upon historical analysis, this December is expected to open bullishly, which it did today by bucking the first trading days recent streak of weakness, then the market is likely to drift sideways to lower into mid-month before rallying to close out the year. The magnitude of the rally will likely largely depend on the Fed. Based upon this expectation, DIA, IWM, QQQ and SPY could be purchased on dips below their buy limits.


 undervalued stocks to buy


For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm



Undervalued Small Cap Stocks


Lower Priced stocks that look to be a buy:


Repro-Med Systems, Inc ( OTCQX:  REPR 0.35 )*   


REPR is now a member of the OTCQX, a leading U.S. Stock Exchange. Repro-Med Systems is a unique U.S. manufacturer of proprietary and patented medical devices world-wide which maintains offices and manufacturing facilities in Chester, NY.  Principal products include the Freedom 60 Syringe Infusion System, RMS High-Flo Subcutaneous Safety Needle Sets and the RES-Q-VAC Medical Suctioning Pump. In addition to being regulated by the FDA which has the authority to approve medical devices for marketing in the U.S., RMS complies with ISO International standards for quality development and manufacturing. RMS Medical Products is a d/b/a of Repro-Med Systems, Inc which was founded in 1980.


The Freedom60 has a proprietary technology that makes it desirable for the delivery of medications in a variety of therapies.  It is very popular for the delivery of subcutaneous immunoglobulin for the treatment of primary immune deficiency disease. The infusion pump uses “dynamic equilibrium” which safely adjusts the flow of medication in accordance with what the patient’s body can accept. This minimizes complications often encountered with other infusion systems which can lead to site reactions and discomfort for the patient. The portability and simple operation of the FREEDOM60 Improves quality of life for patients who otherwise might have to use a complicated electronic pump mounted to a cumbersome infusion pole. Patients then don’t have to be confined.


RMS High-Flo Subcutaneous Safety Needle Sets are being welcomed by healthcare providers and patients alike for their consistently high quality. The infusion sets are an ideal companion for the company’s FREEDOM 60 pump. The needle sets are patented and approved by the FDA. There has not been a new technology in needles other than Repro Med’s vastly better needle sets in quite some time.


RES-Q-VAC is a hand-held suction pump used to clear a patient’s airway or for other purposes when reliable hospital quality suctioning is needed. It uses patented technology to protect users from airborne pathogens and spillage of suctioned material. It is used by emergency service personnel and other first responders, as well as in hospitals and other institutions. There also is a version for use by dentists. RES-Q-VAC is invaluable in the event  of disasters where power is lost because it doesn’t require electricity.


The Freedom 60 Syringe Infusion System is a method for administering medication through a small needle to the subcutaneous tissue, which is the fatty tissue just under the skin. Subcutaneous infusion allows medication into the vascular system more slowly. Combined with more frequent delivery this provides more consistent and stable blood levels. The elimination of large swings in these levels decreases side effects improving overall quality of life. RMS provides High-Flo needles to optimize liquid flow. Their smaller 26 gauge high flow needle flows at the same rate as the considerably larger 24 gauge needles, which are considerably less painful when entering the skin.

The Freedom 60 has had great success in Europe reflected in a huge sales increase of 47.8% first quarter 2015 up from same quarter 2014.


Repro-Med Systems, Inc has had an increase in sales each of the last four years. They finished the year of 2014 with $ 11.2 million in sales reflecting top line growth of  29% from 2013.In each of the previous two years they had a 12% increase in sales. The company has had at least $ 700 thousand of net income in each of the past four years and has no debt. The patented needle sets alone can give the company a huge growth potential. In my opinion, with new products coming on stream, the stock should trade between $ 3 and $ 8 in the next two years.




Enzo Biochem ( ENZ 4.51 ) Bought at our price of $ 2.78. 


This turbulent market has had an effect on the price of Enzo Biochem. The markets, in my opinion, have been in a rotating correction and in some instances, a bear market for some months. It appears that the cause of this is China but I am sure that there are other factors. If you remember the ‘flash crash” of 2010 the market correction was over quickly and those that held through that market decline profited handsomely over the years after the crash. I think that the market is giving us another chance to buy Enzo Biochem at a bargain price. The Company’s fiscal year was over July 31.


I would imagine the Quarter and Year results will be made available by mid-October. With the cash settlement in two litigations the cash position should show a major improvement. Top line revenues should also show an improvement. Depending on R&D expenses and litigation expenses the net loss should also show improvement. At today’s price of $2.90 the Company is valued at approximately $130 million and with revenues approaching $100 million or 1.3 times revenues.


The last Craig Hallum report had a fair value of Enzo’s business of $6 per share. When AmpiProbe is approved and into the market that number is projected at $14 per share. There is always risk in the market so the investment is not without risk but if held over time should deliver handsome profits off of today’s price. Items to look forward to by the end of the year would be litigation news and an AmpiProbe decision all of which should have a positive impact on the stock price.


ProtoKinetix, Incorporated ( PKTX: 0.09 8)

ProtoKinetix (www.protokinetix.com) is trading at $ 0.0521 low and 0.0969 high on Friday has a huge upside potential. They are in collaboration with the James Shapiro laboratory at the University of Alberta. The sole intention of the collaboration is to develop a commercial product pipeline of therapeutic applications for the AAGP™ family of molecules.

Dr. Shapiro is presenting his work at a symposium in Australia tonight and we should see some reaction to his work…We will also try to have him give us an update to the story for our radio show in the next few weeks.

Professor James Shapiro is Professor of Surgery, Medicine and Surgical Oncology, and Director of the Clinical Islet Transplant Program and the Living Donor Liver Transplant Program at the University of Alberta in Edmonton, Canada. He has a busy hepatobiliary surgical practice in HPB oncology, and in liver and kidney-pancreas transplant surgery. His center carries out 80 liver transplants per year, and has done around 80 living donor liver transplants. The University of Alberta just celebrated their 1000th liver transplant.

Dr. Shapiro directs the largest clinical islet transplant program worldwide with almost 170 patients treated, and led the clinical team that developed the “Edmonton Protocol” – the first trial to achieve consistent 100% insulin independence in a series of islet-alone transplant recipients with Type 1 diabetes (published in the NEJM 2000). Before Dr. Shapiro’s trial, the success rate with islet transplantation was less than 8%. He led an international multicenter trial to replicate these findings in 9 international centers (published in NEJM 2006).

Over the last 32 months Dr. Shapiro and his team have been extensively testing the AAGP™ molecule in allogeneic transplants using  human islet cells as the model. As regenerative medicine is rapidly becoming adopted in the treatment of degenerative diseases, the protection of the transplanted cells, tissues, and organs is of paramount importance. Transplanted cells and tissues are subjected to extreme stress factors that, unless protected, could cause failure to graft or premature death. The success of the tests  conducted in Edmonton have demonstrated that AAGP™ has the potential to be widely adopted in many areas of regenerative medicine.


Immune Therapeutics ( OTCQB: IMUN  $ 0.18 )

Appears ready to go: get Long. This biotechnology company is seeking to commercialize patented therapies in emerging nations that combat chronic, life-threatening diseases by rebalancing the immune system.


iSign Media Solutions  ( ISDSF: $ 0.14 ) ISD in Canada (0.17-0.18 ).


The beauty of buying the stock in the USA ..You get a discount of 0ver 20%  because the dollar is much stronger than the Canadian dollar.

iSIGN Media Solutions Inc is public company trading on the Toronto Stock Exchange Venture market under the symbol ISD (TSX-V: ISD), and in the United States  under the symbol of ISDSF. iSIGN became a public entity in September 2009.

iSIGN is a Software as a Service (“SaaS”) company whose US patented software (patent # 8,781,887 B2, received in July 2014) is a unique ‘push and pull’ technology that utilizes Bluetooth and Wi-Fi to ‘push’ messages in any language to mobile devices within a 300 ft (100 meter) radius of our technology, while gathering valuable information from the interaction of our technology with mobile devices within range of our hardware.

Technology Overview

The technology is housed within hardware devices built for the commercial market; are waterproof and fully tested to operate within extreme temperature ranges of -40° to +185° Fahrenheit. The technology does not involve apps and related downloads in order to receive and view messages and as messages are delivered by Bluetooth and Wi-Fi, there is no cost to the end user.

As we ‘push’ messages, we are ‘pulling’ information into our back-end reporting system,  that allows for real-time reporting to our clients. The ‘pulled’ information is completely anonymous, in that it cannot in any way identify the individual that our technology is interacting with. Some of the information gathered includes the make and model of the mobile device; acceptance or rejection of messages;, date, time and location of each interaction; and time spent within range of our system. All of which is information that is considered to be ‘Big Data’ is of considerable interest to users of our technology, as well as to data integrators.

Mission Statement

To create a National and International Mobile Network allowing for location-based interactive proximity mobile marketing; thus providing brands, stores and third party data aggregators a data mining machine that allows for trends and activity to be viewed and analyzed.

We live in a world where our mobile devices have become extensions of ourselves. We depend on them for instant connections to entertainment, social media, news, and deals. The phone has become our ticket, loyalty card, and catchall wallet. Networks are faster; phones are smarter and the mobile shopper is ready to spend money now.

Customer Targeting

Our technology and products can be employed across multiple channels from general retail outlets to real estate. Essentially, our technology and products can be utilized wherever a seller wishes to interact with shoppers in proximity to their location. Our initial customer targeting is convenience stores and gas stations, as this is a fast growing channel, that has over 150,000 locations, with approximately 126,600 linked to gas stations in the US, generating in excess of $700 billion in annual revenue. The problem faced by C-store/gas stations, is that 37% of their customers pay at the pump and don’t step foot within the store. Margins at the pump are 5.1%, while store margins are 22.4%. The average inside sale is only $4.85. All quoted figures taken from the 2013 NACS Annual Report. These problems can easily be addressed and mitigated by using our products.

Recent Developments

In late October iSIGN signed a Licensing/Original Equipment Manufacturer Agreement with Rich Multimedia Technologies (“RMT”) to integrate iSIGN’s Smart Antenna into RMT’s Tele-Digital Store Front Kiosk (essentially a digital signage kiosk). iSIGN will receive a licensing fee based on built units and will also receive a data management fee once the Kiosk is activated. The total fee per Kiosk is $3 US per day. RMT is immediately constructing 5,000 Kiosks for Mexico (airport, transit system and government offices) and has a roll-out plan for a further 3,600 Kiosks into various international airports in the US and Canada.


This company is a very attractive speculation and its acceptance into airports and many other retail outlets could make this a profitable company with 30- 50 million in revenue in 2016. The profit margins to iSign Media are 60-70% of revenue. We believe that this stock could trade at 1.00-3.00 per share in the next year.




Fundamental Analysis Stocks To Buy with Stops


Banner ( BANR: $ 51.32 ) is a bank holding company operating in the Northwest with offices in Walla Walla, Washington State. They have over 1,000 employees.


The KRE is an ETF specializing in smaller regional banking. We are long both with stops.


The airlines are doing well. Both the LUV and  VA are doing well. We have raised the stops. United Airlines is too cheap. We want to be a buyer. Both  Intel and Kroger are excellent positions. Hold.  Enzo Biochem ( ENZ ) remains cheap. Hold.


Continue to add to Bank of America on dips. We have not been able to get filled on theoretical orders to buy Microsoft and Deere. Corning has a stop loss at $ 16.75.



  Name Business Description PE P/S MV mln Price Buy Limit Stop Loss

Or sold

MSFT Microsoft Technology Software, Services, Devices 17 4.7 431B 53.93 53


BANR Regional Bank Offers Banking Products 18 7.12 1.8B 51.32 50.70


KRE Regional  Spider Investments in Small Banks 2.4B 45.02 45.05


GLW Corning Optical Technologies

Glassware, Ceramics

12.5 2.4 22.5B 18.03 18.78


DE Deere Farm and Construction equipment 13 0.84 26.3B 79.59 77.50


KR Kroger Food Mfg and Processing 18 0.33 37B 40.55 36.76


INTC Intel Technology chips platforms processors 13.6 2.8 152.83B 34.94 30.48


VA Virgin Air Regional Airlines 7.2 1.0 1.5B 37.79 32.20


LUV Southwest Air Regional Airlines 16 1.15 22.6B 49.41 33


ENZ Enzo Biochem Life Sciences NA 1.35 134M  4.52 2.78


BAC Bank of America Commercial Bank 10 2.02 165.3B 17.80 15.65sco 16.92x
HDGE Advisor Shares Ranger Bear ETF 10.46  

NOTE: This is a Sample Issue Only!



Visit: PrincetonResearch.com/join.htm



For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm



Rule 17B Attestations and Disclaimers


Princeton Research, Inc. has approximately 2,581,578 shares of AIVN both free and restricted and represents them for Investor relations. Princeton also has about 40,000 shares of TXGE. Princeton is paid $ 1,500 per month from RMS Medical Products. Princeton has bought 81,100 shares of RMS Medical Products. Princeton was paid $ 2,500 to write a report on Xinergy. Princeton has signed a contract with CBLI to be paid $ 2500 for July and August for investor relations. Princeton has been engaged by Target Energy. No contract is currently in place. Princeton was paid about 500,000 restricted shares of Leo Motors.


When there is no movement in penny stocks, even though there is none or very small losses, we will liquidate ( sold AIVN on stop ) even though we like the company, if money is needed for better opportunities.


We now believe REPR represents upside opportunity. The Target ADR trades at about $ 4.50 in U.S. vs 0.05 in Australia. Princeton owns 400,000 Australia shares and about 900 U.S. ADR’s.


Pursuant to the provisions of Rule 206 (4) of the Investment Advisers Act of 1940, readers should recognize that not all recommendations made in the future will be profitable or will equal the performance of any recommendations referred to in this e-mail issue. Princeton may buy or sell its free-trading shares in companies it represents at any time.




Please Direct All Inquiries To:


Mike King

(702) 650-3000



Charles Moskowitz

 (781) 826-8882



Princeton Research

3887 Pacific Street,

Las Vegas, Nevada 89121


Stock Market Investing Strategies

Options Trading Newsletter